Borosil Scientific Ltd Hits All-Time Low Amidst Prolonged Underperformance

Recent Price Movement and Market Context

On the day of the new low, Borosil Scientific’s share price declined by 0.44%, outperforming the Sensex’s fall of 0.97% but underperforming the Glass sector, which dropped by 3.45%. The stock has been on a consecutive two-day decline, losing 2.04% over this period. Notably, Borosil Scientific is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum.

Over longer durations, the stock’s performance has been markedly subdued. It has delivered a negative return of 20.16% over the past year, contrasting sharply with the Sensex’s positive 9.98% gain. Year-to-date, the stock is down 14.41%, while the Sensex has declined by 5.54%. The underperformance extends to the three-month and one-week periods as well, with losses of 17.73% and 6.59% respectively, both exceeding the benchmark’s declines. Over three and five years, Borosil Scientific’s returns have stagnated at 0.00%, while the Sensex has surged by 36.65% and 60.05% respectively. The ten-year comparison is even more stark, with the Sensex appreciating 232.06% against no growth for Borosil Scientific.

Financial Metrics and Profitability Analysis

The company’s financial indicators reveal a subdued profitability profile. Borosil Scientific’s average Return on Equity (ROE) stands at 4.53%, a figure that reflects limited efficiency in generating profits from shareholders’ funds. This low ROE is a key factor behind the stock’s current Sell grade, which was downgraded from Strong Sell on 11 Feb 2026, according to MarketsMOJO’s assessment. The company’s Mojo Score is 37.0, reinforcing the cautious stance.

Growth metrics over the past five years further illustrate the company’s challenges. Net sales have expanded at an annualised rate of 9.80%, while operating profit growth has been modest at 2.86%. Despite this, the stock’s valuation remains relatively expensive, trading at a Price to Book Value of 2.3, which is higher than the average historical valuations of its peers. This valuation premium contrasts with the company’s subdued growth and profitability metrics.

Interestingly, while the stock has declined by over 20% in the last year, reported profits have increased by 11% during the same period. This divergence suggests that market sentiment and valuation pressures have outweighed recent earnings improvements.

Shareholding and Market Perception

Domestic mutual funds hold a minimal stake of just 0.04% in Borosil Scientific Ltd. Given their capacity for detailed research and due diligence, this limited exposure may indicate a cautious approach towards the stock’s current valuation or business outlook. The company’s low debt-to-equity ratio, averaging zero, suggests a conservative capital structure, which contrasts with the subdued market enthusiasm.

Recent Quarterly Performance

In the December 2025 quarter, Borosil Scientific reported positive results following two consecutive quarters of negative performance. Profit Before Tax (PBT) excluding other income reached Rs.12.15 crores, representing a substantial growth of 154.5% compared to the previous four-quarter average. Operating profit before depreciation, interest, and tax (PBDIT) was the highest recorded at Rs.17.19 crores. The operating profit margin relative to net sales also peaked at 14.17% during this quarter, indicating an improvement in operational efficiency despite the broader challenges.

Comparative Sector and Index Performance

Within the Industrial Products sector, Borosil Scientific’s performance has lagged behind the broader market and sector indices. The Glass sector, to which the company belongs, declined by 3.45% on the day the stock hit its all-time low. Over the past year, the BSE500 index has outperformed Borosil Scientific, highlighting the stock’s relative weakness. This underperformance extends across multiple time frames, including one year, three months, and three years, underscoring the persistent nature of the stock’s challenges.

Valuation and Market Capitalisation

Borosil Scientific’s market capitalisation grade is rated 4, reflecting its mid-tier size within the Industrial Products sector. Despite the company’s scale, the stock’s valuation metrics have not translated into positive returns for shareholders over the medium to long term. The Price to Book Value ratio of 2.3 indicates that the stock is trading at a premium relative to its book value, which may be a factor in its subdued market performance given the company’s modest profitability and growth rates.

Summary of Key Performance Indicators

The company’s financial and market indicators collectively paint a picture of a stock facing considerable headwinds. Key points include:

• New 52-week and all-time low price of Rs.99.3 recorded on 2 Mar 2026.
• Negative returns of 20.16% over the past year, significantly underperforming the Sensex.
• Average ROE of 4.53%, indicating limited profitability per unit of shareholder equity.
• Modest five-year growth rates: 9.80% for net sales and 2.86% for operating profit.
• Positive quarterly results in Dec 2025 with PBT excluding other income growing 154.5% versus prior averages.
• Minimal domestic mutual fund ownership at 0.04%, suggesting restrained institutional interest.
• Trading below all major moving averages, signalling ongoing bearish sentiment.

These factors collectively underscore the stock’s current position at an all-time low, reflecting a combination of valuation pressures, subdued growth, and market sentiment within the Industrial Products sector.

Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today